Background: Bariatric surgery is technically demanding surgery performed on high-risk patients. Previous studies using administrative databases have shown a relationship between surgeon volume and patient outcome after Roux-en-Y gastric bypass (RYGB). We examined the relationship between surgeons' annual RYGB volumes and 30-day patient outcomes at 10 centers within the United States. Methods: The Longitudinal Assessment of Bariatric Surgery (LABS)-1 is a prospective study examining the 30-day adverse outcomes after bariatric surgery. The outcomes after RYGB were adjusted by procedure type (open versus laparoscopic), functional status, body mass index, history of deep vein thrombosis, pulmonary embolism, and obstructive sleep apnea. The data were examined to determine the nature and strength of the association between surgeon volume and patients' short-term (30-day) adverse outcomes after RYGB.
Obesity is a major public health issue in the United States and worldwide. According to the Centers for Disease Control and Prevention, in 2007, 26.3% of the U.S. population was considered obese (body mass index [BMI] Ͼ30 kg/m 2 ) [1] . This percentage has been steadily increasing, from 15 .9% in 1995 to 20.1% in 2000. Worldwide, obesity is an increasing problem for both developed and developing nations. The World Health Organization has predicted that Ͼ700 million adults will be obese by 2015 [2] . The increasing prevalence of obesity has been associated with an increasing incidence of type 2 diabetes, cardiovascular disease, and some cancers.
For obese patients, the low levels of weight loss achieved through nonoperative means, combined with the high levels of recidivism, led the National Institutes of Health to convene a Consensus Development Conference, leading to a consensus statement in 1991 [3] . This 19-year-old document has advocated considering bariatric surgery for severely obese patients who have been unsuccessful at nonoperative weight loss. In 2003, Ͼ100,000 bariatric surgical procedures were performed in the United States, and Ͼ80% of these were Roux-en-Y gastric bypass (RYGB) procedures [4] . Laparoscopic RYGB remains the most frequently performed bariatric procedure in the United States, although interest is growing in laparoscopic adjustable gastric banding [5] and, more recently, sleeve gastrectomy [6] .
RYGB is a technically demanding operation, and patients undergoing bariatric surgery are frequently at high surgical risk. The reported mortality rates have varied from .2% to 2% for RYGB [7, 8] . Furthermore, serious complications such as anastomotic leak and pulmonary embolism have been reported in .6 -4.4% of patients [9] .
Previous investigators have examined the relationship between hospital or surgeon volume and complication rates after RYGB [10 -15] . All were conducted using administrative databases with limited information on patient comorbidities and outcomes. These studies have reported mixed findings on whether surgeon volume influences patient outcome.
In an attempt to improve the outcomes of patients undergoing bariatric surgery, 2 "center of excellence" accreditation programs have been developed in the United States. One is overseen by the Surgical Review Corporation [16] and the other by the American College of Surgeons [17] . Both of these programs require that accredited bariatric centers have Ն2 surgeons who perform an average of Ն50 bariatric procedures annually. Prospective testing of this volume threshold has not been published in peer-reviewed publications.
The Longitudinal Assessment of Bariatric Surgery (LABS) is a multicenter observational cohort study conducted by the National Institute of Diabetes, Digestive and Kidney Diseases in the National Institutes of Health. The LABS involves the prospective, standardized, and comprehensive collection of clinical data and includes several related studies. LABS-1 included the 30-day outcome data from consecutive patients, Ն18 years old, who were undergoing an initial bariatric procedure.
The aim of the present study was to determine the relationship between surgeon volume of gastric bypass procedures and patient outcome in LABS-1 patients undergoing RYGB and to investigate the volume threshold of 50 cases annually for the 30-day outcome measure.
Methods
The LABS-1 procedures were conducted by 33 LABScertified surgeons at the University of Pittsburgh Medical Center (Pittsburgh, PA), New York-Presbyterian Hospital (Columbia and Weill-Cornell Medical Centers) (New York, NY), the East Carolina Medical Center (Greenville, NC), the MeritCare Health Systems through the Neuropsychiatric Research Institute (Fargo, ND), Sacramento Bariatric Medical Associates (Sacramento, CA), the University of Washington Medical Center or Virginia Mason Medical Center (Seattle, WA), and the Oregon Health and Sciences University or Legacy Good Samaritan Hospital (Portland, OR). The institutional review board at each institution approved the LABS-1 protocol and consent form.
The LABS-1 inclusion criteria and data collection have previously been described in detail [18] . The data were collected prospectively from consecutive patients aged Participating surgeons completed a questionnaire regarding their previous experience in bariatric surgery before participating in the LABS (lifetime number of cases performed, number of years performing bariatric surgery, and volume during the preceding 12 months). The number of lifetime cases was collected in categories of 0 -24, 25-99, 100 -499, 500 -999, 1000 -1499, 1500 -1999, 2000 -2999, and Ն3000 separately for each procedure type. For the purposes of analysis, a surgeon's lifetime experience was represented by the mid-point of the lifetime experience category. A surgeon's volume in the LABS was calculated as the ratio of the total number of RYGB procedures performed by that surgeon in the LABS and the number of years between the first and last RYGB procedure included in the LABS for that surgeon.
In addition to postoperative mortality, data were collected regarding the composite event (CE) created for the LABS-1 main report [19] . The CE was defined as the occurrence of any 1 of the following events: death, venous thrombosis, pulmonary embolism, reoperation, nondischarge at 30 days, and repeat hospitalization within 30 days after the initial discharge.
The patient and surgeon characteristics have been described using summary statistics such as frequencies, percentages, means, 95% confidence intervals (CIs), medians, and quartiles. Characteristics across categories were compared using Pearson's chi-square test for categorical variables and the Kruskal-Wallis test for continuous variables.
To summarize the 30-day adverse outcomes across the different categories of surgeon and patient characteristics, we used crude incidence rates and 95% CIs. Multilevel univariate and multivariate generalized linear Poisson regression models were used to evaluate the relative risk (RR) of the 30-day CE. Level 1 variables included patient demographic and health status characteristics, and level 2 variables included the surgeon experience and volume variables. Clustering among patients undergoing surgery at the same site and by the same surgeon was accounted for using different random intercepts for the sites and for the surgeons within the site. Because the focus of the present analysis was on surgeon volume, the multivariate model included the surgeon characteristics, along with other patient-level characteristics that had previously been shown to be associated with the 30-day outcome in the LABS-1 [19] . The results are presented using RRs and 95% CIs. Because the unadjusted relationship between the 30-day adverse outcome and the BMI showed a quadratic pattern, both linear and quadratic terms of BMI were considered as predictors in the model. For all tests, P Ͻ.05 was considered statistically significant. The predicted event rates for a surgeon were calculated by averaging the predicted rates of a CE for 
Results
The LABS-1 data set included 3412 first-time RYGB operations of a total of 5069 bariatric operations performed by 33 surgeons. Two surgeons had performed only 1 RYGB operation each and were excluded from the analysis, leaving 3410 RYGB operations and 31 surgeons. Of the 31 surgeons, 15 had performed an average of Յ49 RYGB operations annually in the LABS. Of the surgeons averaging Ն50 RYGB operations annually, 9 had averaged 50 -99 and 7 had averaged Ն100. For the 30 surgeons for whom selfreported surgeon experience data were available, one half had performed bariatric surgery for Ն5 years before participating in the LABS, with 7 surgeons having Ն10 years of bariatric surgery experience. The number of cases performed in the 12 months preceding LABS participation was 20 -450 cases (median 117.5). The median estimated number of lifetime cases before LABS was 649, with one quarter of surgeons having performed Ͼ1000 cases.
Of the 3410 patients who underwent RYGB, 437(12.8%) had undergone open RYGB. The median age was 44.0 years, the median BMI was 47.2 kg/m 2 , 19.8% were men, and 89.1% were white. More than one half (56.2%) of the participants had had Ն2 of the recorded co-morbidities, with hypertension the most common (55.7%) followed by obstructive sleep apnea (50.5%), diabetes (35.9%), and asthma (23.8%). The incidence of these characteristics was similar to that in the full LABS-1 cohort [19] and are listed in Tables 1 and 2 . Of the 3410 patients, 15 died (.4%) and 177 (5.2%) had Ն1 of the adverse outcomes included in the composite endpoint. The distribution of adverse outcomes according to surgeon annual case volume is provided in Table 3 . No significant difference was observed between the mortality rates for low-and high-volume surgeons, although the present study had little power to detect any but extreme differences. As the surgeon annual RYGB case volume increased, however, the percentage of participants with a CE decreased significantly. On univariate analysis, a surgeon's LABS RYGB volume was inversely associated with the CE (RR .89 per 10 cases/yr, 95% CI .84 -.95). Patient BMI, functional status, history of deep vein thrombosis, and history of obstructive sleep apnea, which had been shown to be significantly associated with adverse outcomes in the full cohort [19] , were also significantly associated in the present subcohort of RYGB patients (Table 4) . After adjusting for procedure type (open versus laparoscopic) and the previously mentioned patient characteristics (i.e., patient BMI, functional status, history of deep vein thrombosis, and history of obstructive sleep apnea), a greater surgeon RYGB volume was associated with lower CE rates (RR .90, 95% CI .82-.98), such that for each 10-case/yr increase in volume, the rate of CEs decreased by 10%. The independent and continuous effect of the surgeon annual RYGB case volume on the predicted CE rate is shown for 4 hypothetical patients in Fig. 1 . The self-reported surgeon experience data (i.e., case volume before LABS, lifetime bariatric experience, and number of years practicing bariatric surgery) were not significantly associated with the CE in either the univariate model or the multivariate model (Table 4) . Two low-volume surgeons had high CE rates. The analysis excluding these 2 surgeons produced a similar result (RR of CE .92, 95% CI .85-.99 per 10 case/yr volume). The surgeons' annual adjustable gastric banding volume within LABS was not significantly associated with the CE rate after RYGB (RR .97, 95% CI .88 -1.07 per 10 laparoscopic gastric banding cases/yr). Furthermore, inclusion of the laparoscopic gastric band volume as a separate adjusting variable in the multivariate model did not affect the association between RYGB volume and RYGB CE rates (RR .90, 95% CI .84 -.97 per 10 RYGB cases/yr).
Discussion
The findings of the present study support the hypothesis that the surgeon annual case volume of RYGB is inversely associated with the risk of adverse postoperative outcomes. This relationship appears continuous, with the risk continuing to decrease as the annual case volume increases. The annual laparoscopic adjustable gastric band volume was not significantly associated with the CE rate after RYGB. No significant associations were found between the self reported surgeon experience before LABS participation and patient short-term adverse outcomes. In the present cohort, mortality was too uncommon to draw any conclusions regarding the surgeon annual case volume and the 30-day postoperative mortality risk.
Although the present study is the first on the volumeoutcome relationship after RYGB using a prospectively collected clinical database, similar findings have been reported in other studies. In 2003, Courcoulas et al. [11] reviewed the outcomes after RYGB in Pennsylvania using an administrative database. They found that surgeons performing Ͻ50 RYGB cases annually had a significantly increased rate of postoperative complications compared with those performing a greater volume. Furthermore, this effect was magnified when the low-volume surgeons were performing surgery in low-volume hospitals. Another study from New York State in 2006 found that both a surgeon volume of Ͻ25 cases annually and a low-hospital volume was associated with an increased risk of complications [15] . That study had also used an administrative database and considered patients undergoing gastroplasty, as well as RYGB, for morbid obesity. Two other studies using administrative databases and considering hospital volume alone also found an association between a low volume and increased postoperative complications [12, 14] . Another study of the complications occurring after RYGB found that hospital size, as determined by the number of beds, rather than the annual hospital case volume, influenced the complication rates [10] .
The concept of a relationship between a low surgeon volume and increased postoperative complications has also been proposed in other surgical disciplines. Most of these studies addressed volume at a hospital level, rather than a surgeon level. The relationships between hospital annual case volume and postoperative outcomes have been described for pancreaticoduodenectomy [20] , abdominal aortic aneurysm repair [21] , Heller myotomy for achalasia [22] , and laparoscopic colorectal surgery [23] . Conversely, a volume outcome study of laparoscopic colorectal surgery, in the setting of a randomized trial, did not find a significant relationship between volume and outcome [24] .
Several explanations for the relationship between surgeon annual case volume and short-term patient safety outcome are possible. High-volume surgeons might be more likely to operate at high-volume hospitals, which might provide better multidisciplinary care [25] . High-volume surgeons might also systematically differ in their technique from low-volume surgeons or vary their technique when operating on high-risk patients.
Another possibility is that the case-mix might be different, with high-volume surgeons operating on proportionally fewer high-risk patients. The extremes of BMI, history of obstructive sleep apnea, history of venous thromboembolism, and an inability to walk 200 ft. have been found to be independent risk factors for a poor outcome in the LABS [19] . The present study found that high-volume surgeons operated on proportionally fewer patients who could not walk 200 ft. than did lower volume surgeons; however, the higher volume surgeons operated on a greater percentage of patients with obstructive sleep apnea than did the lower volume surgeons. The prevalence of other risk factors was similar between the low-and high-volume surgeons. The relationship between surgeon volume and the composite endpoint persisted even after adjusting for these risk factors.
The present study did not find a statistically significant difference between the surgeon experience data before participation in the LABS and the outcome of short-term patient safety. It is possible that a real effect was missed owing to the self-reported and categorical nature of the data. The surgeon experience (i.e, Ն25 cases of gastric bypass, adjustable gastric banding, vertical banded gastroplasty, or biliopancreatic diversion plus "minimal" experience with each procedure performed on a LABS participant) and credentialing requirements for the LABS (i.e., medical degree, general surgery residence training, board certification or FACS or FRCSC) might have negated the learning curve effect of pre-LABS experience in the study surgeons. It is also possible that the current volume is more important than previous or lifetime experience in RYGB in terms of the postoperative complication rates.
The LABS-1 study involved only a small proportion of bariatric centers and surgeons within the United States. All hospitals were accredited centers of excellence by the end of the LABS. The minimal standards for surgeon experience and hospital facilities that must be met for such accreditation led to a highly standardized study environment; however, it might have limited the generalizability of these findings to other bariatric surgeons and centers.
It is noteworthy that a relationship between volume and outcome was demonstrated within the tightly controlled environment of the present study. Even when minimal standards are set for surgeon experience and hospital facilities, an increased surgeon annual RYGB case volume was still associated with decreased postoperative CE rates. The observed relationship between the annual RYGB volume and CE rate was continuous and did not suggest any specific annual volume threshold for surgeon credentialing requirements. The effect of the specific surgeon and hospital processes on outcome will be addressed in future studies.
